PubRank

Loredana Sarmati

Author PubWeight™ 39.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies. Blood 2012 2.51
2 Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother 2007 1.89
3 A relapsing inflammatory syndrome and active human herpesvirus 8 infection. N Engl J Med 2005 1.63
4 Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 2005 1.55
5 Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy. J Med Virol 2003 1.36
6 Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART. J Med Virol 2005 1.32
7 Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. J Clin Microbiol 2002 1.32
8 Primary human herpesvirus 8 infection in immunocompetent children. JAMA 2002 1.13
9 Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010 1.05
10 Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors. Antimicrob Agents Chemother 2010 1.04
11 Baseline cellular HIV DNA load predicts HIV DNA decline and residual HIV plasma levels during effective antiretroviral therapy. J Clin Microbiol 2011 0.98
12 Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation. J Med Virol 2009 0.98
13 HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens. Curr HIV Res 2008 0.97
14 Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon. J Med Virol 2012 0.96
15 Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression. Hepatology 2015 0.91
16 Erysipeloid cutaneous metastasis from bladder carcinoma. Eur J Dermatol 2007 0.91
17 High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. Curr HIV Res 2016 0.91
18 HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro. Antiviral Res 2011 0.90
19 Prevalence trend and correlates of HHV-8 infection in HIV-infected patients. J Acquir Immune Defic Syndr 2002 0.90
20 Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS 2002 0.89
21 Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A 2012 0.84
22 KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection. J Med Virol 2011 0.82
23 High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis. J Clin Microbiol 2003 0.81
24 Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. J Antimicrob Chemother 2012 0.80
25 Procalcitonin is a reliable marker of severe systemic infection in neutropenic haematological patients with mucositis. Am J Hematol 2010 0.80
26 Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy. J Infect 2011 0.80
27 Non-B HIV type 1 subtypes: replicative capacity and response to antiretroviral therapy. AIDS Res Hum Retroviruses 2004 0.79
28 Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages. PLoS One 2013 0.79
29 Does the risk of abortion increase in women with high human herpesvirus-8 antibody titers? J Infect Dis 2003 0.79
30 Impact of HIV-1 tropism on the emergence of non-AIDS events in HIV-infected patients receiving fully suppressive antiretroviral therapy. AIDS 2016 0.79
31 HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy. AIDS 2012 0.78
32 Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood 2002 0.78
33 A case of rhabdomiolysis associated with raltegravir use. AIDS 2010 0.77
34 Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. AIDS 2002 0.77
35 Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers. Expert Opin Biol Ther 2013 0.77
36 Viral growth assay to evaluate the replicative capacity of HIV-1 isolates. J Virol Methods 2004 0.76
37 A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. BMC Infect Dis 2013 0.75
38 Reply to "Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides", by Barreiro et al. AIDS 2003 0.75
39 Stavudine protective function and emergence of Lamivudine resistance. Antimicrob Agents Chemother 2003 0.75
40 Advances in herpesvirus diagnosis. Herpes 2006 0.75
41 Human immunodeficiency virus polymorphisms and zidovudine resistance. Antimicrob Agents Chemother 2003 0.75
42 HIV-associated primary cutaneous anaplastic large cell lymphoma: a clinicopathological subset with more aggressive behavior? Case report and review of the literature. J Cutan Pathol 2012 0.75
43 Total HIV-1 DNA detection and quantification in peripheral blood by COBAS®AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0. Clin Chem Lab Med 2016 0.75
44 Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV. Eur J Epidemiol 2004 0.75